Enquiry/Quote

How to Source Tranexamic Acid Tablet for Pharmaceutical Formulation

Tranexamic Acid Tablet (Tablets, 500 mg, 650 mg) is classified under Critical Care. It is therapeutically aligned with reference brands such as Lysteda®(US). This guide highlights key sourcing factors buyers should consider when procuring high-quality Tranexamic Acid Tablet for formulation, R&D, or bulk manufacturing.

Product Overview: Tranexamic Acid, an antifibrinolytic, prevents excessive bleeding in surgeries and trauma. Available in 500 mg tablets and 100 mg/mL IV injections, it’s marketed as Cyklokapron®, Lysteda®, and Exacyl®. Pharma B2B platforms offer global buyers compliant, bulk sourcing of tranexamic acid from trusted, GMP-certified manufacturers. Tranexamic Acid is an antifibrinolytic agent used to reduce or prevent excessive bleeding in surgica...

Tranexamic Acid Tablet API in Tablets form, 500 mg, 650 mg specification
Tranexamic Acid Tablet API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Tranexamic Acid Tablet must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Tranexamic Acid Tablet is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Tranexamic Acid Tablet is more than procurement—it’s a strategic partnership. With its tablets form and 500 mg, 650 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Tranexamic Acid Tablet.

Request a Quote

Frequently Asked Questions For Sourcing of Tranexamic Acid Tablet

What is the typical lead time for Tranexamic Acid Tablet?

Lead times range from 4–6 weeks depending on supplier and region.

Is Tranexamic Acid Tablet available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Tranexamic Acid Tablet require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Tranexamic Acid Tablet?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Tranexamic Acid Tablet?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Tranexamic Acid Tablet?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Tranexamic Acid Tablet suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Tranexamic Acid Tablet be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.